Regulation

A standardized annual review that does not account for the adviser’s actual activities, conflicts, and regulatory risks may fail to identify the types of issues highlighted by the SEC.

According to CMS, all 50 states, DC, and Puerto Rico have applied to join the CMS GENEROUS Model, which aims to lower Medicaid prescription drug costs through MFN pricing.

ESMA’s report highlights a range of investor protection and market integrity concerns, drawing attention to the gap between regulation in Europe and the US.

The new members will reshape the influential panel that guides what preventative services will be covered by the Affordable Care Act.

Federal proposal would bar for-profit corporations and private equity firms from owning or controlling medical practices.

Nearly 600 FDA-required post-market studies for drugs and devices are delayed, raising questions of safety as regulators pursue faster approvals.

With the CLARITY Act blocked, the Commission is granting temporary and conditional exemptive relief for on-chain securities trading.

Act brings new EU-wide frameworks for R&D procurement, intellectual property valuations, and regulatory sandboxes to speed up innovation.